The VISTA trial is evaluating and comparing 2 dose levels of laru-zova with an untreated control group for the treatment of X-linked retinitis pigmentosa (XLRP).

Every home tells a story—a narrative of comfort, taste, and practicality. The ideal residence isn’t just a structure of walls and beams; it’s a dynamic space shaped by the evolving needs and ...

The new Vantage S brings additional chassis and powertrain upgrades to the already impressive Aston Martin sports car.

Authors noted it may be worthwhile to explore whether oral methylphenidate affects myopia by influencing dopamine levels ...

AOL’s most legendary hacker built his seminal app through trial and error—the same way he rebuilt his life.

Apple last month announced its latest update for MacOS 26, codenamed "Tahoe." It's full of new visual design elements like Apple's Liquid Glass design theme, better integration with the iPhone, and a ...

Atsena Therapeutics expands its ATSN-201 trial for X-linked retinoschisis, a step toward the first gene therapy treatment.

A balanced diet is not a trend it’s the baseline for good health strong immunity stable energy and emotional balance ...

IndieWire looks at recent films from Jafar Panahi, Nader Saei-Var, and more to consider how hijab is represented in Iranian ...

The biotech will add a pivotal Phase III cohort to its ongoing Phase I/II trial evaluating ATSN-201 in X-linked retinoschisis ...

Topline data expected in H2 2026 LONDON and CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited ("Beacon Therapeutics" or "the Company"), a leading clinical-stage ...

Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides clear regulatory pathway to approval in a continuous Phase 1 / 2 / 3 study, avoiding the requirement for an additional registr ...